MedTrace Logo

The Efficacy of Neuromuscular Electrical Stimulation to Attenuate Muscle Loss

NCT01521637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2015-08-19

No results posted yet for this study

Summary

Subjects who are hospitalized in the ICU will be included after 24 hours of intubation during their ICU stay. Twice-daily Neuromuscular Electrical Stimulation (NMES) will be performed on one leg for 2x40 min per day to assess muscle fiber size. The investigators hypothesize an attenuated loss in muscle fiber size.

Conditions

  • Muscle Disuse
  • Neuromuscular Electrical Stimulation (NMES)
  • Critical Illness

Interventions

PROCEDURE

Neuromuscular Electrical Stimulation of m. quadriceps femoris

Neuromuscular Electrical Stimulation of m. quadriceps femoris by using a commercially available muscle stimulator

PROCEDURE

Sham-treatment: no NMES

Sham comparator

Sponsors & Collaborators

  • Hasselt University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2015-04-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01521637 on ClinicalTrials.gov